Screening Repurposed Antiviral Small Molecules as Antimycobacterial Compounds by a Lux-Based phoP Promoter-Reporter Platform

• Egile Nagusiak: Li Zhu (Egilea), Annie Wing-Tung Lee (Egilea), Kelvin Ka-Lok Wu (Egilea), Peng Gao (Egilea), Kingsley King-Gee Tam (Egilea), Rahim Rajwani (Egilea), Galata Chala Chaburte (Egilea), Timothy Ting-Leung Ng (Egilea), Chloe Toi-Mei Chan (Egilea), Hiu Yin Lao (Egilea), Wing Cheong Yam (Egilea), Richard Yi-Tsun Kao (Egilea), Gilman Kit Hang Siu (Egilea)
• Formatua: Liburua
• Argitaratua: MDPI AG, 2022-03-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

The emergence of multidrug-resistant strains and hyper-virulent strains of <i>Mycobacterium tuberculosis</i> are big therapeutic challenges for tuberculosis (TB) control. Repurposing bioactive small-molecule compounds has recently become a new therapeutic approach against TB. This study...